2024
Distinct characteristics and prognosis of IgA nephropathy patients with nephrotic syndrome: a propensity score-matched cohort study
Jiang Y, Chen P, Zhao W, Liu L, Shi S, Lv J, Zhang H. Distinct characteristics and prognosis of IgA nephropathy patients with nephrotic syndrome: a propensity score-matched cohort study. Frontiers In Medicine 2024, 11: 1344219. PMID: 38439903, PMCID: PMC10910015, DOI: 10.3389/fmed.2024.1344219.Peer-Reviewed Original ResearchNephrotic syndromeEnd-stage kidney diseaseNS patientsIgAN patientsComposite endpointRisk of composite endpointElevated serum uric acid levelsSerum uric acid levelsNon-NS groupLow C3 levelsScore-matched cohort studyIgA nephropathy patientsUric acid levelsIncreased complement activationSevere foot process effacementMESTC scoreFoot process effacementPropensity score matchingRemission rateSevere hematuriaRenal biopsyActive diseaseClinical characteristicsNephropathy patientsPoor prognosis
2013
Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin
Moeckel GW, Luciano RL, Brewster UC. Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin. Clinical Kidney Journal 2013, 6: 507-509. PMID: 26120444, PMCID: PMC4438392, DOI: 10.1093/ckj/sft076.Peer-Reviewed Case Reports and Technical NotesAcute kidney injuryTubular injuryIgA nephropathyMild IgA nephropathyAcute tubular injuryLong-term anticoagulationDirect thrombin inhibitorKidney injurySevere hematuriaRenal biopsyGlomerular pathologyDabigatranPatientsThrombin inhibitorsNephropathyInjuryWarfarinAnticoagulationHematuriaAspirinBiopsyPathology
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply